SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-003212
Filing Date
2021-01-06
Accepted
2021-01-06 16:43:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d64878d424b5.htm 424B5 883431
2 GRAPHIC g64878g76b56.jpg GRAPHIC 38400
  Complete submission text file 0001193125-21-003212.txt   937506
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237175 | Film No.: 21511214
SIC: 2836 Biological Products, (No Diagnostic Substances)